Cargando…
Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome - authors' response
Autores principales: | Toms, Tracey E, Panoulas, Vasileios F, John, Holly, Douglas, Karen MJ, Kitas, George D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787288/ http://dx.doi.org/10.1186/ar2806 |
Ejemplares similares
-
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study
por: Toms, Tracey E, et al.
Publicado: (2009) -
Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study
por: Toms, Tracey E, et al.
Publicado: (2008) -
Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome
por: Raterman, Hennie G, et al.
Publicado: (2009) -
Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis
por: Daoussis, Dimitrios, et al.
Publicado: (2009) -
Dyslipidaemia in Rheumatological Autoimmune Diseases
por: Toms, Tracey E, et al.
Publicado: (2011)